News

Based on the data presented, the FDA’ Oncologic Drugs Advisory Committee (ODAC) recommended that the combination of Doxil (doxorubicin HCI liposome injection) and docetaxel did not provide a

Merck & Co., Schering-Plough and their cholesterol joint venture – Merck/Schering-Plough Pharmaceuticals, have reached a civil settlement with a multistate group of attorneys general representing 35 states and

Celesio has acquired Laboratoria Flandria. The acquisition is an addition to the existing network of Celesio’s Belgian subsidiaries. The company expects to utilise further synergies and to offer

Taro has received patent covering its Ovide (malathion) lotion, 0.5% (patent no. US 7,560,445) from the US Patent and Trademark Office. The patent is for a highly pure

Array BioPharma has announced the filing of an investigational new drug (IND) application with the FDA, to initiate a phase 1 clinical trial in cancer patients with MEK

Cadence’s New Drug Application (NDA) for Acetavance (intravenous acetaminophen) has been accepted for filing by the FDA, and is designated for Priority Review. The drug will be used

Cornerstone has submitted a regulatory filing with the Food and Development Authority (FDA) for an extended-release antitussive product – CRTX 067. Craig Collard, president and CEO of Cornerstone,

Saudi Basic Industries (Sabic) has commissioned unit Yansab 2290.SE, to start production from its petrochemical complex in Yanbu – as reported in Reuters. The launch was delayed for

Ivax has signed an amended distribution agreement with Immco. The agreement provides Diamedix rights to distribute Immco’s portfolio of products in the US, with additional strategic initiatives related